Medicine

A. Gillespie
{"title":"Medicine","authors":"A. Gillespie","doi":"10.2307/j.ctv131bwn0.42","DOIUrl":null,"url":null,"abstract":"Background: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Owing to the complexity of NAFLD pathogenesis, there is still no specific medication for NAFLD that is safe and effective. Yinchenwuling Powder (YCWLP), a classic Chinese formula, has been widely applied to NAFLD and its efficacy has been proven in numerous studies. However, systematic evaluation of the efficacy and safety of YCWLP for NAFLD is still lacking. Methods: We will search 8 databases to collect randomized controlled trials of patients with NAFLD treated in the YCWLP from the database inception to September 30, 2022. Two researchers will independently perform the selection of studies, data extraction, and assessment of the risk of bias. The Cochrane Review Manager (RevMan5.4) software will be used for data synthesis and analysis. Results: Comprehensive evidence of YCWLP for the treatment of NAFLD will be provided in this study. Conclusion: The efficacy and safety of YCWLP in treating NAFLD will be proved, providing feasible and effective clinical recommendations for the treatment of NAFLD.","PeriodicalId":11487,"journal":{"name":"Edinburgh Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Edinburgh Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2307/j.ctv131bwn0.42","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Owing to the complexity of NAFLD pathogenesis, there is still no specific medication for NAFLD that is safe and effective. Yinchenwuling Powder (YCWLP), a classic Chinese formula, has been widely applied to NAFLD and its efficacy has been proven in numerous studies. However, systematic evaluation of the efficacy and safety of YCWLP for NAFLD is still lacking. Methods: We will search 8 databases to collect randomized controlled trials of patients with NAFLD treated in the YCWLP from the database inception to September 30, 2022. Two researchers will independently perform the selection of studies, data extraction, and assessment of the risk of bias. The Cochrane Review Manager (RevMan5.4) software will be used for data synthesis and analysis. Results: Comprehensive evidence of YCWLP for the treatment of NAFLD will be provided in this study. Conclusion: The efficacy and safety of YCWLP in treating NAFLD will be proved, providing feasible and effective clinical recommendations for the treatment of NAFLD.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
医学
背景:非酒精性脂肪性肝病(NAFLD)是世界范围内最常见的肝脏疾病。由于NAFLD发病机制的复杂性,目前仍没有安全有效的特异性药物治疗NAFLD。银晨五灵散(YCWLP)是中药经典方剂,被广泛应用于NAFLD治疗,其疗效已被大量研究证实。然而,YCWLP治疗NAFLD的有效性和安全性的系统评价仍然缺乏。方法:我们将检索8个数据库,收集从数据库建立到2022年9月30日在YCWLP治疗的NAFLD患者的随机对照试验。两名研究人员将独立进行研究选择、数据提取和偏倚风险评估。使用Cochrane Review Manager (RevMan5.4)软件进行数据合成和分析。结果:本研究将提供YCWLP治疗NAFLD的综合证据。结论:YCWLP治疗NAFLD的有效性和安全性将得到证实,为治疗NAFLD提供可行有效的临床建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Medicine Anticoagulants Diseases of the Eye Anticoagulants Surgery
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1